Providing Eligible Patients Access to the Medicines They Need

BRIDGES TO ACCESS® offers non-oncology medicines—at no cost—to patients who qualify.

At GSK, we believe that access to medicines is important. That's why we created Bridges to Access, a patient assistance program that provides GSK prescription non-oncology medicines to qualified patients who need help paying for treatment.

Bridges to Access offers GSK medicines to eligible patients at no cost. Patients can apply directly to Bridges to Access; advocates are not required for enrollment unless the patient needs a prescription filled that same day. Bridges to Access representatives are available to answer your questions 8:00 am to 8:00 pm ET, Monday through Friday. Assistance is available in Spanish and many other languages at 1-866-728-4368 / La asistencia está disponible en español y muchos otros idiomas, 1-866-728-4368.

Find out whether you or a patient you know may be eligible for this program.

If you are prescribing Avandia® (rosiglitazone maleate) Tablets, Avandaryl® (rosiglitazone maleate and glimepiride) Tablets or Avandamet® (rosiglitazone maleate and metformin hydrochloride) Tablets, please click here for additional information.

Two Ways to Enroll

For Patients Who Want to Self-Enroll

Patients may enroll in Bridges to Access on their own by completing an application and faxing or mailing it in.

When Medicine Is Needed Immediately

Patients in need of medicine before receiving mail order shipments should be enrolled by an Advocate (i.e. someone such as a healthcare worker, social worker, or case worker, who is involved in the delivery of your healthcare).

GSK Corporation    GSK For You

This website is funded and developed by GlaxoSmithKline.
This site is intended for US residents only.
© 1997-2014 GlaxoSmithKline. All Rights Reserved.
Legal Notices | Privacy Statement | Contact Us